These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 12372940

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure.
    Blumberg A, Weidmann P, Shaw S, Gnädinger M.
    Am J Med; 1988 Oct; 85(4):507-12. PubMed ID: 3052050
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients.
    Kim HJ.
    Nephron; 1996 Oct; 72(3):476-82. PubMed ID: 8852501
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of oral glucose administration on serum potassium concentration in hemodialysis patients.
    Muto S, Sebata K, Watanabe H, Shoji F, Yamamoto Y, Ohashi M, Yamada T, Matsumoto H, Mukouyama T, Yonekura T, Namiki S, Kusano E.
    Am J Kidney Dis; 2005 Oct; 46(4):697-705. PubMed ID: 16183425
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mineralocorticoid therapy lowers serum potassium in patients with end-stage renal disease.
    Singhal PC, Desroches L, Mattana J, Abramovici M, Wagner JD, Maesaka JK.
    Am J Nephrol; 1993 Oct; 13(2):138-41. PubMed ID: 8342580
    [Abstract] [Full Text] [Related]

  • 11. Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol.
    Allon M, Shanklin N.
    Am J Kidney Dis; 1996 Oct; 28(4):508-14. PubMed ID: 8840939
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Glycyrrhetinic acid food supplementation lowers serum potassium concentration in chronic hemodialysis patients.
    Farese S, Kruse A, Pasch A, Dick B, Frey BM, Uehlinger DE, Frey FJ.
    Kidney Int; 2009 Oct; 76(8):877-84. PubMed ID: 19641483
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia.
    Fishbane S, Ford M, Fukagawa M, McCafferty K, Rastogi A, Spinowitz B, Staroselskiy K, Vishnevskiy K, Lisovskaja V, Al-Shurbaji A, Guzman N, Bhandari S.
    J Am Soc Nephrol; 2019 Sep; 30(9):1723-1733. PubMed ID: 31201218
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches.
    Ngugi NN, McLigeyo SO, Kayima JK.
    East Afr Med J; 1997 Aug; 74(8):503-9. PubMed ID: 9487416
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.